Crinetics Pharmaceuticals, Inc. (CRNX)
47.90
+0.50
(+1.05%)
USD |
NASDAQ |
Dec 09, 16:00
47.86
-0.04
(-0.09%)
After-Hours: 20:00
Crinetics Pharmaceuticals EPS Diluted (Quarterly): -1.381 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Amgen, Inc. | 5.934 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| United Therapeutics Corp. | 7.161 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -130.09M |
| Revenue (Quarterly) | 0.143M |
| Total Expenses (Quarterly) | 130.23M |
| Enterprise Value | 3.502B |
| Gross Profit Margin (Quarterly) | -607.7% |
| Profit Margin (Quarterly) | -90.97K% |
| Earnings Yield | -9.47% |
| Normalized Earnings Yield | -9.466 |